Characterizing Human Exceptional Longevity
Characterizing Human Exceptional Longevity
批准号:
7913647
负责人:
THOMAS T PERLS
金额:
$7.17万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-15 至 2011-08-31
关键词:
Activities of Daily LivingAgeAgingAmericanAwardBehavioral GeneticsBioethicsCardiovascular DiseasesCardiovascular systemCentenarianClinicalClinical InvestigatorClinical ResearchClinical TrialsCollectionCommunitiesDataDiabetes MellitusDiseaseEducationEnrollmentEnsureEpidemiologic StudiesEpigenetic ProcessFacultyFamilyFamily StudyFamily memberFundingFutureGenerationsGeneticGenetic MaterialsGeriatricsGoalsGrantHandHealthHumanIndividualK-Series Research Career ProgramsLifeLipidsLongevityMedical StudentsMentorsMentorshipMolecular GeneticsNew EnglandNuclear FamilyPaperPatternPersonalityPhenotypePhysiciansPrevalenceProbabilityProtocols documentationPublic HealthPublishingQualifyingRecruitment ActivityRecurrenceReligionResearchResearch PersonnelResourcesRiskSchoolsScientistSiblingsSiteSpiritualityStagingStrokeStudentsSurvivorsTraining ProgramsTranslatingUnited States National Institutes of Healthage relatedbasecareercareer developmentcohortcopingdisabilityend of lifeexperiencegenetic associationgenetic epidemiologygenetic linkagegenetic pedigreememberoffspringpatient oriented researchpopulation basedpre-doctoralprofessorrepositorysegregationtransmission process
中文摘要
这是一个修订后的应用程序中的职业生涯研究者奖以患者为导向的研究(K24)。的
申请人,博士托马斯珀尔斯,是医学和老年医学副教授和创始人和董事
新英格兰百岁老人研究获得了NIH医生科学家奖(K-12)和保罗
Beeson Faculty Scholar in Aging Research Award,Perls博士继续成为一名独立的科学家
致力于病人导向的研究具体来说,通过这些早期的指导奖,博士珀尔斯
在对一个非常老的队列进行基于人群的表型研究方面发展了专业知识。他
他还获得了另外四项NIH赠款(RO-3、R-21和两项R 0 - 1),证明了他的独立性。珀尔斯医生
在学生和临床研究者职业生涯的各个阶段都有大量的指导记录。
他指导了五名美国老龄化研究联合会医学生老年医学学者,三名
医学预科和研究生院学生,两名老年病学研究员,一名博士预科研究员和一名助理
老年医学教授所有这些学员都成功地与Perls博士一起发表了论文。同时开展
他的R 01资助的研究的目的,一个基于人口的百岁老人和他们的生物人口学研究,
家庭,这个K24赠款规定,15%的努力将致力于收集初步数据和发展
申请资助百岁老人的遗传流行病学研究。Perls博士将参加
生物伦理学、负责任地开展临床调查和遗传流行病学作为其职业生涯的一部分
与发展相关的教育目标。这些百岁老人的研究为学员提供了肥沃的土壤,
临床研究的实践经验。卓越的使用寿命,
从灵性、个性、适应能力和功能储备,到人口统计学和临床研究
表观遗传学关联的观察。35%的工作将致力于指导现有和未来
学员一个庞大而多样化的学术社区,拥有广泛的培训计划,将确保
一个高素质和有才华的学员充足的池。
与公共卫生的相关性:在珀尔斯博士的指导下,
学员,从学生到初级教师,肥沃的土壤,为学习广泛的方面成功
从宗教、个性、适应能力和功能储备到环境、行为和
与特殊生存率的基因关联随后的研究结果可能最终转化为战略
帮助人们更成功地衰老。
英文摘要
This is a revised application for a Mid-Career Investigator Award in Patient-Oriented Research (K24). The
applicant, Dr. Thomas Perls, is an Associate Professor of Medicine and Geriatrics and Founder and Director
of the New England Centenarian Study. Having received an NIH physician scientist award (K-12) and a Paul
Beeson Faculty Scholar in Aging Research Award, Dr. Perls proceeded to become an independent scientist
devoted to patient-oriented research. Specifically, through these earlier mentored awards, Dr. Perls
developed expertise in conducting a population-based phenotypic study of an extremely old cohort. His
independence is demonstrated by his receipt of four other NIH grants (RO-3, R-21 and two R0-1s). Dr. Perls
has a substantial record of mentoring students and clinical investigators at various stages of their careers.
He has mentored five American Federation of Aging Research Medical Student Geriatrics Scholars, three
premedical and pre-graduate school students, two geriatrics fellows, a pre-doctoral fellow and an Assistant
Professor in Geriatrics. All of these trainees successfully published papers with Dr. Perls. While carrying out
the aims of his R01-funded study, a population-based bio-demographic study of centenarians and their
families, this K24 grant provides that 15% effort will be devoted to gathering preliminary data and developing
applications to fund a genetic epidemiological study of centenarians. Dr. Perls will attend courses in
bioethics, responsible conduct of clinical investigations and genetic epidemiology as a part of his career
development-related education goals. These centenarian studies provide fertile ground for mentees to gain
hands-on experience in clinical research. Innumerable aspects of exceptional longevity are available for
study from spirituality, personality, adaptive capacity and functional reserve, to demographic and clinical
observations to epigenetic associations. 35% effort will be dedicated to mentoring established and future
mentees. A large and diverse academic community with a broad spectrum of training programs will ensure
an ample pool of highly qualified and talented mentees.
Relevance to public health: The study of human exceptional longevity under Dr. Perls's mentorship, provides
trainees, from students to junior faculty, fertile ground for studying a broad range of aspects of successful
aging from religion, personality, adaptive capacity and functional reserve to environmental, behavioral and
genetic associations with exceptional survival. Subsequent findings may ultimately translate into strategies
that help people age more successfully.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10276390
-
项目类别:
-
资助金额:$20.08万
-
财政年份:2021
-
负责人:THOMAS T PERLS
-
依托单位:
Administrative Core
-
批准号:10689331
-
项目类别:
-
资助金额:$19.1万
-
财政年份:2021
-
负责人:THOMAS T PERLS
-
依托单位:
Identifying protective omics profiles in centenarians and translating these into preventive and therapeutic strategies
-
批准号:10017131
-
项目类别:
-
资助金额:$430.23万
-
财政年份:2019
-
负责人:THOMAS T PERLS
-
依托单位:
Identifying protective omics profiles in centenarians and translating these into preventive and therapeutic strategies
-
批准号:10678171
-
项目类别:
-
资助金额:$499.8万
-
财政年份:2019
-
负责人:THOMAS T PERLS
-
依托单位:
Identifying protective omics profiles in centenarians and translating these into preventive and therapeutic strategies
-
批准号:10449626
-
项目类别:
-
资助金额:$33.78万
-
财政年份:2019
-
负责人:THOMAS T PERLS
-
依托单位:
Phenotyping Core
-
批准号:10388280
-
项目类别:
-
资助金额:$683.97万
-
财政年份:2019
-
负责人:THOMAS T PERLS
-
依托单位:
Phenotyping Core
-
批准号:10616715
-
项目类别:
-
资助金额:$213.45万
-
财政年份:2019
-
负责人:THOMAS T PERLS
-
依托单位:
Protein Signatures of APOE2 and Cognitive Aging
-
批准号:10451539
-
项目类别:
-
资助金额:$45.56万
-
财政年份:2018
-
负责人:THOMAS T PERLS
-
依托单位:
Protein Signatures of APOE2 and Cognitive Aging
-
批准号:10219143
-
项目类别:
-
资助金额:$64.14万
-
财政年份:2018
-
负责人:THOMAS T PERLS
-
依托单位:
Protein Signatures of APOE2 and Cognitive Aging
-
批准号:10408304
-
项目类别:
-
资助金额:$32.28万
-
财政年份:2018
-
负责人:THOMAS T PERLS
-
依托单位:
Characterizing Human Exceptional Longevity
-
批准号:8143141
-
项目类别:
-
资助金额:$3.24万
-
财政年份:2006
-
负责人:THOMAS T PERLS
-
依托单位:
Characterizing Human Exceptional Longevity
-
批准号:7030623
-
项目类别:
-
资助金额:$13.29万
-
财政年份:2006
-
负责人:THOMAS T PERLS
-
依托单位:
Characterizing Human Exceptional Longevity
-
批准号:7189048
-
项目类别:
-
资助金额:$13.15万
-
财政年份:2006
-
负责人:THOMAS T PERLS
-
依托单位:
Characterizing Human Exceptional Longevity
-
批准号:7370992
-
项目类别:
-
资助金额:$13.51万
-
财政年份:2006
-
负责人:THOMAS T PERLS
-
依托单位:
Characterizing Human Exceptional Longevity
-
批准号:7572824
-
项目类别:
-
资助金额:$14.28万
-
财政年份:2006
-
负责人:THOMAS T PERLS
-
依托单位:
The Long Life Family Study
-
批准号:8144308
-
项目类别:
-
资助金额:$75.73万
-
财政年份:2004
-
负责人:THOMAS T PERLS
-
依托单位:
Exceptional survival and longevity in New England
-
批准号:7126256
-
项目类别:
-
资助金额:$3.72万
-
财政年份:2004
-
负责人:THOMAS T PERLS
-
依托单位:
Exceptional survival and longevity in New England
-
批准号:6943503
-
项目类别:
-
资助金额:$75.0万
-
财政年份:2004
-
负责人:THOMAS T PERLS
-
依托单位:
Long Life Family Study: Boston Field Center
-
批准号:8695587
-
项目类别:
-
资助金额:$129.52万
-
财政年份:2004
-
负责人:THOMAS T PERLS
-
依托单位:
The Long Life Family Study
-
批准号:8319402
-
项目类别:
-
资助金额:$75.39万
-
财政年份:2004
-
负责人:THOMAS T PERLS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: